Stay updated with breaking news from Viewpoint Molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that the December 13t...
SBIR Phase II Grants bring the cumulative grant total to approximately $17 million from the National Institutes of Health and National Cancer InstituteCORALVILLE, IA / ACCESSWIRE / October 11, 2022 / Viewpoint
Dr. Puhlmann has over 20 years of oncology drug development experience and has spearheaded the global development and approval of multiple cancer drugsCORALVILLE, IA / ACCESSWIRE / October 4, 2022 / Viewpoint
Isoray, Inc. (NYSE:NYSE:ISR) Q4 2022 Earnings Conference Call September 28, 2022, 4:30 PM ET Company Participants Mark Levin - Investor Relations Lori Woods - Chief Executive Officer Thijs...
Established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industriesCORALVILLE, IA / ACCESSWIRE / February 22, 2022